Swiss National Bank’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-53,800
| Closed | -$253K | – | 2652 |
|
|
2021
Q1 | $253K | Hold |
53,800
| – | – | ﹤0.01% | 2477 |
|
|
2020
Q4 | $385K | Hold |
53,800
| – | – | ﹤0.01% | 2478 |
|
|
2020
Q3 | $574K | Hold |
53,800
| – | – | ﹤0.01% | 2332 |
|
|
2020
Q2 | $679K | Buy |
53,800
+800
| +2% | +$10.1K | ﹤0.01% | 2292 |
|
|
2020
Q1 | $485K | Hold |
53,000
| – | – | ﹤0.01% | 2198 |
|
|
2019
Q4 | $739K | Buy |
53,000
+1,200
| +2% | +$16.7K | ﹤0.01% | 2286 |
|
|
2019
Q3 | $891K | Buy |
51,800
+6,300
| +14% | +$108K | ﹤0.01% | 2115 |
|
|
2019
Q2 | $1.24M | Buy |
45,500
+10,200
| +29% | +$278K | ﹤0.01% | 1996 |
|
|
2019
Q1 | $676K | Hold |
35,300
| – | – | ﹤0.01% | 2276 |
|
|
2018
Q4 | $332K | Hold |
35,300
| – | – | ﹤0.01% | 2454 |
|
|
2018
Q3 | $668K | Hold |
35,300
| – | – | ﹤0.01% | 2334 |
|
|
2018
Q2 | $690K | Buy |
35,300
+5,900
| +20% | +$115K | ﹤0.01% | 2348 |
|
|
2018
Q1 | $552K | Hold |
29,400
| – | – | ﹤0.01% | 2341 |
|
|
2017
Q4 | $488K | Buy |
+29,400
| New | +$488K | ﹤0.01% | 2417 |
|